Concepedia

James C. Geoghegan

JC

32

Publications

2.8K

Citations

28

H-Index

2004

Active since

Affiliations

Adimab (United States)(Current)

Dartmouth College

Scripps Research Institute

International AIDS Vaccine Initiative

United States Army Medical Research Institute of Infectious Diseases

James C. Geoghegan is an author at Adimab (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2004–2023

32

Publications

32

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku et al. · Science · 2021 · 382 citations · Full text

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

May Kung Sutherland, James C. Geoghegan, Changpu Yu et al. · Bone · 2004 · 236 citations

, , +12

Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids

Nathan R. Deleault, Justin R. Piro, Daniel J. Walsh et al. · Proceedings of the National Academy of Sciences · 2012 · 231 citations · Full text

Prolonged evolution of the human B cell response to SARS-CoV-2 infection

Mrunal Sakharkar, C. Garrett Rappazzo, Wendy Wieland‐Alter et al. · Science Immunology · 2021 · 199 citations · Full text

Protease-resistant Prion Protein Amplification Reconstituted with Partially Purified Substrates and Synthetic Polyanions

Nathan R. Deleault, James C. Geoghegan, Koren Nishina et al. · Journal of Biological Chemistry · 2005 · 191 citations · Full text

Rows per page

1–5 of 32